Immune Checkpoint Inhibitors 'High-Risk Yet Promising' for Cancer Patients Who Undergo Organ Transplant
May 28, 2025
May 28, 2025
BUFFALO, New York, May 28 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Immune Checkpoint Inhibitors 'High-Risk Yet Promising' for Cancer Patients Who Undergo Organ Transplant
BUFFALO, N.Y. -- A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhib . . .
* * *
Immune Checkpoint Inhibitors 'High-Risk Yet Promising' for Cancer Patients Who Undergo Organ Transplant
BUFFALO, N.Y. -- A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhib . . .
